Free Trial

InMed Pharmaceuticals (INM) Competitors

InMed Pharmaceuticals logo
$4.70 +0.47 (+11.11%)
(As of 01:51 PM ET)

INM vs. AIM, SLGL, NLSP, WENA, SNSE, NKGN, AWH, TLPH, TSBX, and CDT

Should you be buying InMed Pharmaceuticals stock or one of its competitors? The main competitors of InMed Pharmaceuticals include AIM ImmunoTech (AIM), Sol-Gel Technologies (SLGL), NLS Pharmaceutics (NLSP), ANEW Medical (WENA), Sensei Biotherapeutics (SNSE), NKGen Biotech (NKGN), Aspira Women's Health (AWH), Talphera (TLPH), Turnstone Biologics (TSBX), and Conduit Pharmaceuticals (CDT). These companies are all part of the "pharmaceutical products" industry.

InMed Pharmaceuticals vs.

InMed Pharmaceuticals (NASDAQ:INM) and AIM ImmunoTech (NYSE:AIM) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, dividends, community ranking, earnings, institutional ownership, risk and profitability.

AIM ImmunoTech received 50 more outperform votes than InMed Pharmaceuticals when rated by MarketBeat users. Likewise, 82.86% of users gave AIM ImmunoTech an outperform vote while only 47.06% of users gave InMed Pharmaceuticals an outperform vote.

CompanyUnderperformOutperform
InMed PharmaceuticalsOutperform Votes
8
47.06%
Underperform Votes
9
52.94%
AIM ImmunoTechOutperform Votes
58
82.86%
Underperform Votes
12
17.14%

InMed Pharmaceuticals has a beta of 0.36, meaning that its stock price is 64% less volatile than the S&P 500. Comparatively, AIM ImmunoTech has a beta of -0.36, meaning that its stock price is 136% less volatile than the S&P 500.

InMed Pharmaceuticals has a net margin of -137.41% compared to AIM ImmunoTech's net margin of -12,594.21%. InMed Pharmaceuticals' return on equity of -65.74% beat AIM ImmunoTech's return on equity.

Company Net Margins Return on Equity Return on Assets
InMed Pharmaceuticals-137.41% -65.74% -53.57%
AIM ImmunoTech -12,594.21%-421.73%-147.54%

InMed Pharmaceuticals has higher revenue and earnings than AIM ImmunoTech. AIM ImmunoTech is trading at a lower price-to-earnings ratio than InMed Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
InMed Pharmaceuticals$4.60M0.74-$7.68M-$13.91-0.34
AIM ImmunoTech$200K67.05-$28.96M-$0.47-0.45

AIM ImmunoTech has a consensus price target of $3.00, indicating a potential upside of 1,325.18%. Given AIM ImmunoTech's stronger consensus rating and higher probable upside, analysts plainly believe AIM ImmunoTech is more favorable than InMed Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
InMed Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
AIM ImmunoTech
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

20.1% of InMed Pharmaceuticals shares are owned by institutional investors. Comparatively, 12.0% of AIM ImmunoTech shares are owned by institutional investors. 1.9% of InMed Pharmaceuticals shares are owned by company insiders. Comparatively, 0.0% of AIM ImmunoTech shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, AIM ImmunoTech had 9 more articles in the media than InMed Pharmaceuticals. MarketBeat recorded 13 mentions for AIM ImmunoTech and 4 mentions for InMed Pharmaceuticals. AIM ImmunoTech's average media sentiment score of 0.52 beat InMed Pharmaceuticals' score of 0.33 indicating that AIM ImmunoTech is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
InMed Pharmaceuticals
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
AIM ImmunoTech
2 Very Positive mention(s)
1 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

InMed Pharmaceuticals and AIM ImmunoTech tied by winning 9 of the 18 factors compared between the two stocks.

Get InMed Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for INM and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INM vs. The Competition

MetricInMed PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$3.38M$6.53B$5.10B$8.84B
Dividend YieldN/A8.11%5.04%4.07%
P/E Ratio-0.345.5095.1214.22
Price / Sales0.74375.021,217.3088.42
Price / CashN/A52.5939.4936.27
Price / Book0.4010.276.976.37
Net Income-$7.68M$153.22M$118.73M$225.56M
7 Day Performance-7.48%-1.19%-1.22%-0.02%
1 Month Performance-18.97%-6.71%-3.07%2.04%
1 Year Performance-38.17%32.39%32.52%28.00%

InMed Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INM
InMed Pharmaceuticals
0.2095 of 5 stars
$4.70
+11.1%
N/A-47.8%$3.38M$4.60M-0.3413
AIM
AIM ImmunoTech
1.7374 of 5 stars
$0.21
+5.3%
$3.00
+1,325.2%
-52.0%$13.41M$200,000.00-0.4520News Coverage
SLGL
Sol-Gel Technologies
3.6128 of 5 stars
$0.48
+8.3%
$5.00
+947.1%
-68.5%$13.30M$1.55M-1.3050News Coverage
Gap Down
NLSP
NLS Pharmaceutics
1.2189 of 5 stars
$3.31
+0.6%
N/A+623.1%$12.64MN/A0.006
WENA
ANEW Medical
N/A$0.73
-0.5%
N/AN/A$12.51MN/A0.00N/AGap Up
SNSE
Sensei Biotherapeutics
4.8056 of 5 stars
$0.48
-2.8%
$4.33
+795.3%
-20.0%$12.17MN/A0.0040News Coverage
NKGN
NKGen Biotech
N/A$0.34
+7.9%
N/A-89.1%$11.94M$80,000.00-0.06N/AGap Up
High Trading Volume
AWH
Aspira Women's Health
1.533 of 5 stars
$0.74
+1.4%
$4.40
+494.6%
-78.5%$11.88M$9.15M-0.64110Analyst Forecast
TLPH
Talphera
2.6915 of 5 stars
$0.69
-2.3%
$4.50
+552.1%
N/A$11.75M$650,000.000.0019Gap Up
TSBX
Turnstone Biologics
3.2023 of 5 stars
$0.48
+4.4%
$2.13
+342.7%
-84.8%$11.10M$19.31M0.0082
CDT
Conduit Pharmaceuticals
N/A$0.11
+21.0%
N/A-92.8%$10.72MN/A0.003News Coverage
Gap Up
High Trading Volume

Related Companies and Tools


This page (NASDAQ:INM) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners